FibroGen (FGEN) Tops Q1 EPS by 11c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.45), $0.11 better than the analyst estimate of ($0.56).

At March 31, 2016, FibroGen had $309.9 million of cash, cash equivalents, investments, receivables and restricted cash

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Home Depot beats estimates, reaffirms fiscal 2026 guidance